The North America proton therapy market size surpassed USD 490 billion in 2025 and is predicted to reach around USD 1508.33 billion by 2035, registering a CAGR of 11.9% from 2026 to 2035. The market growth is fueled by the rising prevalence of cancer.

North America Proton Therapy Market Statical Scope

The proton therapy market is growing due to rising cases of cancer and increasing awareness of proton therapy. The cancer centres are investing in precision radiation technologies that reduce radiation exposure and damage to surrounding healthy tissue.

Market growth is supported by continuous advancement in treatment precision, strong reimbursement policies and growing partnerships between healthcare providers and technology companies.

North America Proton Therapy Market Share, By Procedure, 2025 (%)

• Accelerators (Cyclotrons, Synchrotrons) - Accelerators (Cyclotrons, Synchrotrons) lead the segment, with a share of 50%, because accelerators are essential components for generating proton beams used in most proton therapy systems.
• Beam Delivery (Pencil Beam Scanning, Passive Scattering, Uniform Scanning) - Beam Delivery (Pencil Beam Scanning, Passive Scattering, Uniform Scanning) accounts for 25% of the market, as these delivery methods are essential for precise proton therapy that targets tumours effectively while minimizing damage to surrounding healthy tissues.

North America Proton Therapy Market Share, By Components, 2025 (%)

• Proton Accelerator - The proton accelerator segment dominated the market with a share of 30%, because these components are used for generating protons and accelerating them to the required energy levels for effective cancer treatment in proton therapy systems.
• Cyclotrons - The cyclotrons segment holds a significant portion, with a share of 20%, supported by the wide usage of cyclotrons due to their cost-effectiveness, reliability, and efficiency in accelerating protons to the required energy levels.

North America Proton Therapy Market Share, By Type, 2025 (%)

• Rotating Proton Therapy Systems - Rotating Proton Therapy Systems dominate with 70% of the market share, due to their flexibility in targeting tumours from various angles. Many large-scale proton therapy facilities prefer them for complex cancer cases.
• Non-Rotating Proton Therapy Systems - Non-Rotating Proton Therapy Systems account for 30% of the market, offering a more cost-effective option for smaller clinics or those with less complex treatment requirements, though they are less flexible in delivering proton therapy compared to rotating systems.

North America Proton Therapy Market Share, By Set-Up Systems, 2025 (%)

• Multi-Room Systems - Multi-Room Systems represent 60% of the market, as they allow multiple patients to be treated simultaneously, thus improving throughput and efficiency in larger medical centers and hospitals.
• Single-Room Systems - Single-Room Systems hold a significant portion, with a share of 40%, due to lower installation costs and space requirements. These systems are preferred by smaller or specialized facilities offering a more compact and cost-effective solution.

North America Proton Therapy Market Share, By Applications, 2025 (%)

• Pediatric Cancer - Pediatric Cancer leads the segment, with a share of 26%, driven by the growing use of proton therapy in pediatric cancer treatments due to its precision in targeting tumours.
• Prostate Cancer - Prostate Cancer holds a significant portion, with a share of 20%, supported by the ability to deliver highly targeted treatment to prostate tumours, reducing the risk of side effects and damage to surrounding sensitive organs such as the bladder and rectum.

North America Proton Therapy Market Share, By End Use, 2025 (%)

• Hospitals - Hospitals dominate with 50% of the market share, driven by integrated oncology departments and advanced radiotherapy infrastructure. Large hospitals have the ability to handle large patient volumes and provide specialised treatments.
• Cancer Research Institutes - Cancer Research Institutes hold 30% of the market, driven by the significant role these institutions play in advancing proton therapy technologies, conducting clinical trials, and exploring new therapeutic applications, which are essential for the ongoing development of proton therapy.
• Ambulatory Surgical Centres - Ambulatory Surgical Centres account for 20% of the market, providing outpatient care and offering patients a convenient alternative for receiving proton therapy treatment without the need for an overnight hospital stay, making it an attractive option for certain patient groups.

Competitive Landscape

Key players in the proton therapy market include Varian Medical Systems (Siemens Healthineers), Mevion Medical Systems, ProNova Solutions, Optivus Proton Therapy, Inc., ProTom International, and Accuray Incorporated. These companies provide advanced proton systems used in cancer treatment, along with supporting technology and services needed to operate these systems. Companies focus on compact proton systems, expanding treatment centre networks and reducing installation costs.

Segments Covered in the Report

By Procedure

• Accelerators (Cyclotrons, Synchrotrons)
• Beam Delivery (Pencil Beam Scanning, Passive Scattering, Uniform Scanning)
• Modulators
• Software
• Services

By Components

• Proton Accelerator
• Cyclotrons
• Synchrotrons
• Synchrocyclotrons
• Linacs
• H-Minus Synchrotrons
• Separated Sector Cyclotrons

By Type

• Rotating Proton Therapy Systems
• Non-Rotating Proton Therapy Systems

By Set-Up Systems

• Multi-Room Systems
  Single-Room Systems

By Applications

• Pediatric Cancer
• Prostate Cancer
• Head and Neck Cancer
• Breast Cancer
• Lung Cancer

By End Use

• Hospitals
• Cancer Research Institutes
• Ambulatory Surgical Centres